Without a companion program, its possible to end up with sarcopenic obesity and a higher body fat composition than before starting the meds up to 40% of weight loss can be muscle
While this hasnt been confirmed in humans, these medications are not recommended for those with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2
A representative Phase 2 escalation schedule looked like this: Lower dose arms were reached with correspondingly fewer steps
In preclinical models, catestatin exhibits anti-inflammatory, antihypertensive, and metabolic effects, and reduced circulating levels have been associated with hypertension, obesity, and insulin resistance (Mahata et al., 1997)
To ease the intensity of any side effects, Camilleri emphasized the importance of starting out at a lower dose or escalating the dosage at a slower rate than what is recommended by the Food and Drug Administration (FDA)
Brehm A, Pfeiler G, Pacini G, Vierhapper H, Roden M